Methicillin-resistance in Staphylococcus aureus - Molecular basis, novel targets and antibiotic therapy

Current Pharmaceutical Design

Volumn 5, Issue 2, 1999, Pages 45-55

  Ehlert, K ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL GROWTH; GENE EXPRESSION; GENE INACTIVATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; DRUG DESIGN; DRUG RESISTANCE, MULTIPLE; FORECASTING; HUMANS; METHICILLIN RESISTANCE; OPERON; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0033009269     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Levy, S. B. Scientific American 1998, 32-39.
2. Hakenbeck, R.; Tarpay, M.; Tomasz, A. Antimicrob. Agents Chemother. 1980, 17, 364-371.
3. Ubukata, K.; Nonoguchi, R.; Matsuhashi M.; Konno M. J. Bacteriol. 1989, 171, 2882-2885.
4. Abraham, E. P.; Chain, E. Nature 1940, 146, 837.
5. Blumberg, H. M.; Rimland, D.; Carroll, D. J.; Terry, P.; Wachsmuth, I. K. J. Infect. Dis. 1991, 163, 1279-1285.
6. Gilpin, M. L.; Milner, P. H. Chemistry in Britain, 1997, 46-48.
7. Neu, H. C. Science. 1992, 257, 1064.
8. Berger-Bächi, B. Trends in Microbiol. 1994, 2, 389-393.
9. de Lencastre, H.; de Jonge, B. L. M.; Matthews, P. R.; Tomasz, A. J. Antimicrob. Chemother. 1994, 33, 7-24.
10. Chambers, H. F. Clinical Microbiology Reviews 1997, 10, 781-791.
11. Brakstad, O. G.; Mæland, J. A. APMIS 1997, 105, 264-276.
12. Labischinski, H.; Ehlert, K.; Berger-Bächi, B. J. Antimicrob. Chemother. 1998, 41, 581-584.
13. Labischinski, H.; Ehlert, K.; Wieland, B. Exp. Opin. Invest. Drugs 1998, 7(8), 1245-1256.
14. Jevons, M. P. Letter Br. Med. J. 1961, 1, 124-125.
15. Benner, E. J.; Kayser, F. H. Lancet 1968, ii, 741-744.
16. Klimek, J. J.; Marsik, F. J.; Bartlett, R. C.; Weir, B.; Shea, P.; Quintiliani, R. Am. J. Med. 1976, 61, 340-345.
17. Haley, R. W.; Hightower, A. W.; Khabbaz, R. F.; Thornsberry, C.; Martone, W. J.; Allen, J. R.; Hughes, J. M. Ann. Intern. Med. 1982, 97, 297-308.
18. Boyce, J. M.; Causey, W. A. Infect. Contr. 1982, 3, 377-382.
19. Mahoney, M. C.; Eckman, M. R.; Stolee, T. A.; Cossalter, D. J. J. Clin. Microbiol. 1984, 20, 1001-1002.
20. Saravolatz, L. D.; Markowitz, N.; Arking, L.; Pohlod, D.; Fisher, E. Ann. Intern. Med. 1982, 96, 11-16.
21. Voss, A.; Milatovic, D.; Wallrauch-Schwarz, C.; Rosdahl, V. T.; Braveny, I. Eur. J. Clin. Microbiol. Infect. Dis. 1994, 13, 50-55.
22. Voss, A.; Doebbeling, B. N. Int. J. Antimicrob. Agents 1995, 5, 101-105.
23. Hiramatsu, K.; Hanaki, H.; Ino, T.; Yabuta, K.; Oguri, T.; Tenover, F. C. J. Antimicrob. Chemother. 1997, 40, 135-146.
24. Hiramatsu, K. Drug Resistance Updates 1998, 1, 135-150.
25. Pujol, M.; Peña, C.; Pallares, R.; Ayats, J.; Ariza, J.; Gudiol, F. Eur. J. Clin. Microbiol. Infect. Dis. 1994, 13, 96-102.
26. Kloos, W. E.; Bannerman, T. L. Clinical Microbiology Reviews 1994, 7, 117-140.
27. Matthews, P. R.; Stewart, P. R. FEMS Microbiol. Lett. 1984, 22, 161-166.
28. Sutherland, R.; Rolinson, G. N. J. Bacteriol. 1964, 87, 887-899.
29. Seligman, S. J. J. Gen. Microbiol. 1966, 42, 315-322.
30. Ryffel, C.; Strässle, A.; Kayser, F. H.; Berger-Bächi, B. Antimicrob. Agents Chemother. 1994, 38, 724-728.
31. Spratt, B. G. Proc. Natl. Acad. Sci. USA 1975, 72, 2999-3003.
32. Spratt, B. G. Eur. J. Biochem. 1977, 72, 341-352.
33. Ghuysen, J. M. Trends Microbiol. 1994, 2, 372-380.
34. Reynolds, P. E. In Antibiotic inhibition of bacterial cell surface assembly and function: P. Actor, L. Daneo-Moore, M. L. Higgins, M. R. Salton and G. D. Shockman, Ed.; American Society for Microbiology, Washington, D. C., 1988, pp. 343-351.
35. Curtis, N. A. C.; Hayes, M. V.; Wyke, A. W.; Ward, J. B. FEMS Microbiol. Lett. 1980, 9, 263-266.
36. Wada, A.; Watanabe, H. J. Bacteriol. 1998, 180, 2759-2765.
37. Beise, F.; Labischinski, H.; Giesbrecht, P. FEMS Microbiol Lett. 1988, 55, 195-202.
38. Chambers, H. F.; Sachdeva, M. J. Infect. Dis. 1990, 161, 1170-1176.
39. Hartman, B. J.; Tomasz, A. J. Bacteriol. 1984, 158, 513-516.
40. de Jonge, B. L. M.; Tomasz, A. Antimicrob. Agents Chemother. 1993, 37,342-346.
41. Pinho, M. G.; Ludovice, A. M.; Wu, S. W.; de Lencastre, H. Microb. Drug Resistance-Mechanisms, Epidemiology, and Disease 1997, 3, 409-413.
42. Hackbarth, C. J.; Kocagoz, T.; Kocagoz, S.; Chambers, H. F. Antimocrob. Agents and Chemother. 1995, 39, 103-106.
43. Henze, U.; Berger-Bächi, B. Antimocrob. Agents and Chemother. 1996, 40, 2121-2125.
44. Beck, W. D.; Berger-Bächi, B., Kayser, F. H. J. Bacteriol. 1986, 165, 373-378.
45. Tesch, W.; Strässle, A.; Berger-Bächi, B.; O'Hara, D.; Reynolds, P.; Kayser, F. H. Antimicrob. Agents and Chemother. 1988, 32, 1494-1499.
46. Kuhl, S. H.; Pattee, P. A.; Baldwin, J. N. J. Bacteriol. 1978, 135, 460-465.
47. Archer, G. L.; Niemeyer, D. M. Trends in Microbiology 1994, 2, 343-347.
48. Tesch, W.; Ryffel, C.; Strässle, A.; Kayser, F. H.; Berger-Bächi, B. Antimicrob. Agents and Chemother. 1990, 34, 1703-1706.
49. Hiramatsu, K.; Asada, K.; Suzuki, E.; Okonogi, K.; Yokota, T. FEBS Letters 1992, 298, 133-137.
50. Kuwahara-Arai, K.; Kondo, N.; Hori, S.; Tateda-Suzuki, E.; Hiramatsu, K. Antimicrob. Agents and Chemother. 1996, 40, 2680-2685.
51. Song, M. D.; Wachi, M.; Doi, M.; Ishino, F.; Matsuhashi, M. FEBS Letters 1987, 221, 167-171.
52. Hackbarth, C. J.; Chambers, H. F. Antimicrob. Agents and Chemother. 1993, 37, 1144-1149.
53. Roychoudhury, S.; Kaiser, R. E.; Brems, D. N.; Yeh, W-K. Antimicrob. Agents and Chemother. 1996, 40, 2075-2079.
54. Toney, J. H.; Hammond, G. G.; Leiting, B.; Pryor, K. D.; Wu, J. K.; Cuca, G. C.; Pompliano, D. L. Analyst. Biochem. 1998, 255, 113-119.
55. Wu, C. Y. E.; Blaszczak, L. C.; Smith, M. C.; Skatrud, P. L. J.Bacteriol. 1994, 176, 1539-1541.
56. Welzel, P. In Antibiotics and antiviral compounds - Chemical synthesis and modification K. Krohn, H. Kirst, and H. Maas, Ed.; VHC, Weinheim 1993, pp. 373-379.
57. Hackbarth, C. J.; Mück, C.; Chambers, H F. Antimicrob. Agents Chemother. 1994, 38, 2568-2571.
58. Berger-Bächi, B.; Strässle, A.; Kayser, F.H. Eur. J. Clin. Microbiol. 1986, 5, 697-701.
59. Berger-Bächi, B. J. Bacteriol. 1983, 154, 479-487.
60. Berger-bächi, B.; Kohler, M. L. FEMS Microbiol. Lett. 1983, 20, 305-309.
61. Berger-Bächi, B.; Barberis-Maino, L.; Strässle, A.; Kayser, F. H. Mol. Gen. Genet. 1989, 219, 263-269.
62. de Jonge, B. L. M.; Chang, Y.-S.; Gage, D.; Tomasz, A. J. Biol. Chem. 1992, 267, 11255-11259.
63. de Lencastre, H.; Tomasz, A. Antimicrob. Agents Chemother. 1994, 38, 2590-2598.
64. de Jonge, B. L. M.; de Lencastre, H.; Tomasz, A. J. Bacteriol. 1991, 173, 1105-1110.
65. Maidhof, H.; Reinicke, B.; Blümel, P.; Berger-Bächi, B.; Labischinski, H. J. Bacteriol. 1991, 173, 3507-3513.
66. Kopp, U.; Roos, M.; Wecke, J.; Labischinski, H. Microbial Drug Resistance-Mechanisms, Epidemiology, and Disease 1996, 2, 29-41.
67. Stránden, A. M.; Ehlert, K.; Labischinski, H.; Berger-Bächi, B. J. Bacteriol. 1997, 179, 9-16.
68. de Jonge, B. L. M.; Sidow, T.; Chang, Y-S.; Labischinski, H.; Berger-Bächi, B.; Gage, D. A.; Tomasz, A. J. Bacteriol. 1993, 175, 2779-2782.
69. Henze, U.; Sidow, T.; Wecke, J.; Labischinski, H.; Berger-Bächi, B. J. Bacteriol. 1993, 175, 1612-1620.
70. Ehlert, K.; Schröder, W.; Labischinski, H. J. Bacteriol. 1997, 179, 7573-7576.
71. Labischinski, H. Med. Microbiol. Immunol. 1992, 181, 241-265.
72. th Intersci. Conf. Antimicrob. Agents Chemother. San Diego, 1998, Poster C-112.
73. Matsuhashi, M.; Dietrich, C. P.; Strominger, J. L. J. Biol. Chem. 1967, 242, 3191-3206.
74. Thorndike, J.; Park, J. T. Biochem. Biophys. Commun. 1969, 35, 642-647.
75. Kamiryo, T.; Matsuhashi, M. J. Biol. Chem. 1972, 247, 6306-6311.
76. Petit, J.-F.; Strominger, J. L.; Söll, D. J. Biol. Chem. 1968, 243, 757-767.
77. Bumsted, R. M.; Dahl, J. L.; Söll, D.; Strominger, J. L. J. Biol. Chem. 1968, 243, 779-782.
78. Roberts, R. J. J. Biol. Chem. 1974, 249, 4787-4796.
79. Green, C. I.; Vold, B. S. J. Bacteriol. 1993, 175, 5091-5096.
80. de Jonge, B. L. M.; Chang, Y.-S.; Gage, D.; Tomasz, A. J. Biol. Chem. 1992, 267, 11248-11254.
81. de Jonge, B. L. M.; Chang, Y.-S.; Xu, N.; Gage, D. Antimicrob. Agents Chemother. 1996, 40, 1498-1503.
82. Ling, B. D.; Berger-Bächi, B. Antimicrob. Agents Chemother. 1998, 42, 936-938.
83. Mei, J.-M.; Nourbakhsh, F.; Ford, C. W.; Holden, D. W. Mol. Microbiol. 1997, 26, 399-407.
84. Alborn, W. E., Jr.; Hoskins, J.; Ünal, S.; Flokowitsch, J. E.; Hayes, C. A.; Dotzlaf, J. E.; Yeh, W. K.; Skatrud, P. L. Gene 1996, 180, 177-178.
85. th Intersci. Conf. Antimicrob. Agents Chemother. Washington, DC. 1994, Abstr. 95.
86. Severin, A.; Schuster, C.; Hakenbeck, R.; Tomasz, A. J. Bacteriol. 1992, 174, 5152-5155.
87. Billot-Klein, D.; Shlacs, D.; Bryant, D.; Bell, D.; van Heijenoort, J.; Gutmann, L. Biochem. J. 1996, 313, 711-715.
88. Climo, M. W.; Patron, R. L.; Goldstein, B. P.; Archer, G. L. Antimicrob. Agents Chemother. 1998, 42, 1355-1360.
89. Berger-Bächi, B.; Strässle, A.; Gustafson, J. E.; Kayser, F. H. Antimicrob. Agents Chemother. 1992, 36, 1367-1373.
90. Ornelas-Soares, A.; de Lencastre, H.; de Jonge, B. L. M.; Gage, D.; Chang, Y.-S.; Tomasz. A. J. Biol. Chem. 1993, 268, 26268-26272.
91. Gustafson, J.; Strässle, A.; Hächler, H.; Kayser, F. H.; Berger-Bächi, B. J. Bacteriol. 1994, 176, 1460-1467.
92. Wu, S.; de Lencastre, H.; Sali A.; Tomasz, A. Microb. Drug Resistance-Mechanisms, Epidemiology and Disease 1996, 2, 277-286.
93. Jolly, L.; Wu, S.; van Heijenoort, J.; de Lencastre, H.; Mengin-Lecreulx, D.; Tomasz, A. J. Bacteriol. 1997, 179, 5321-5325.
94. Ornelas-Soares, A.; de Lencastre, H.; de Jonge, B. L. M.; Tomasz, A. J. Biol. Chem. 1994, 269, 27246-27250.
95. Ludovice, A. M.; Wu, S.; de Lencastre, H. Microb. Drug Resistance-Mechanisms, Epidemiology and Disease 1998, 4, 85-90.
96. Balaban, N.; Goldkorn, T.; Nhan, R. T.; Dang, L. B.; Scott, S.; Ridgley, R. M.; Rasooly, A.; Wright, S. C.; Larrick, J. W.; Rasooly, R.; Carlson, J. R. Science, 1998, 280, 438-440.
97. Bugg, T. D. H.; Dutka-Malen, S.; Arthur, M.; Courvalin, P.; Walsh, C. T. Biochemistry, 1991, 30, 2017-2021.
98. Noble, W. C.; Virani, Z.; Cree, R. G. A. FEMS Microbiol. Lett. 1992, 72, 195-198.
99. Schwalbe, R. S.; Stapleton, J. T.; Gilligan, P. H.; New Engl. J. Med. 1987, 316, 927-931.
100. Hiramatsu, K.; Aritaka, N.; Hanaki, H.; Kawasaki, S.; Hosoda, Y.; Hori, S.; Fukuchi, Y.; Kobayashi, I. Lancet 1997, 350, 1670-1673.
101. Hanaki, H.; Kuwahara-Arai, K.; Boyle-Vavra, Daum, R. S.; Labischinski, H.; Hiramatsu, H. J. Antimicrob. Chemother. 1998, 42, 199-209.
102. Hanaki, H.; Labischinski, H.; Inaba, Y.; Kondo, N.; Murakami, H.; Hiramatsu, K. J. Antimicrob. Chemother. 1998, 42, 315-320.
103. Chant, C.; Rybak, M. J. Ann. Pharmacother. 1995, 29, 1022-1027.
104. Hooper, D. C. In Antibacterial Therapy: Achievements, Problems and Future Perspectives. W. D. Busse, H.-J. Zeiler, and H. Labischinski, Ed.; Springer Verlag, Berlin, Heidelberg, New York 1997, pp. 27-36.
105. Bryskier, A. Exp. Opin. Invest. Drug 1997, 6, 1227-1245.
106. Jones, R. N.; Barret, M. S.; Erwin, M. E. Antimicrob. Agents Chemother. 1997, 41, 488-493.
107. th Intersci. Conf. Antimicrob. Agents Chemother. San Diego, 1998, Poster C-110.
108. Jorgensen, J. H.; McElmeel, M. L.; Trippy, C. W. Antimicrob. Agents Chemother. 1997, 41, 465-467.
109. Ford, C. W.; Hamel, J. C.; Stapert, D.; Moerman, J. K.; Hutchison, D. K.; Barachyn, M. R.; Zurenko, G. E. Trends Microbiol. 1997, 5, 196-200.
110. Billot-Klein, D.; Gutmann, L.; Bryant, D.; Bell, D.; van Heijenoort, J.; Grewal, J., Shlaes, D. M. J. Bacteriol. 1996, 178, 4696-4703.
111. Schleifer, K. H.; Kandler, O. Bacteriol. Rev. 1972, 36, 407-477.